What changes have been made to the “Sequence Listing” requirements for applications filed on or after July 1, 2022?
For patent applications filed on or after July 1, 2022, there have been significant changes to the “Sequence Listing” requirements. The MPEP section 2424.01 includes an important editor’s note:
“[Editor Note: This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). See MPEP §§ 2412 – 2419 for guidance on WIPO ST.26 requirements for applications filed on or after July 1, 2022.]“
This note indicates that new requirements based on the World Intellectual Property Organization (WIPO) Standard ST.26 have been implemented for applications filed on or after July 1, 2022. Applicants should refer to MPEP §§ 2412 – 2419 for detailed guidance on these new requirements, which cover the disclosure of nucleotide and amino acid sequences in patent applications.
To learn more: